Statement of Retraction: Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
- PMID: 38758364
- DOI: 10.1080/0167482X.2024.2346385
Statement of Retraction: Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Retraction of
-
Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.J Psychosom Obstet Gynaecol. 2018 Dec;39(4):307-314. doi: 10.1080/0167482X.2017.1383381. Epub 2017 Oct 5. J Psychosom Obstet Gynaecol. 2018. Retraction in: J Psychosom Obstet Gynaecol. 2024 Dec;45(1):2346385. doi: 10.1080/0167482X.2024.2346385. PMID: 28980870 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources